Article metrics
Other content recommended for you
- Disease modifying therapies for relapsing multiple sclerosis
- Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
- Predicting and preventing the future: actively managing multiple sclerosis
- Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis
- Disease-modifying therapies for multiple sclerosis
- Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry
- Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
- Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis
- Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study
- Multiple sclerosis